John F. Bedard
Mr. Bedard has served as a director since January 2006. Mr. Bedard has been
engaged as a principal in a pharmaceutical consulting practice since
2002. Prior to that, he served in senior management positions during
a 15 year career at Bristol-Myers Squibb, most recently as Vice
President, FDA Liaison and Global Strategy. In that position, Mr.
Bedard was the liaison with the FDA for new drug development, and
he was also responsible for global development plans and registration
activities for new drugs. Before his tenure at Bristol-Myers Squibb,
Mr. Bedard held senior regulatory affair positions at Smith Kline
& French Laboratories and Ayerst Laboratories.
